20.2% Below Target

The consensus Wall Street price target for PATH is $14, representing 20.2% upside from the current price of $11.65. With 24 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

PATH has a consensus rating of "Hold" based on 24 Wall Street analysts. The rating breakdown is mixed, with 16 Hold ratings making up the largest segment. The consensus 12-month price target of $14 implies 20.2% upside from current levels.

With a forward P/E of 17.2977x, PATH trades at a relatively low valuation. The consensus target of $14 implies 20.2% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $18 for PATH, while the most conservative target is $12. The consensus of $14 represents the median expectation. Our quantitative valuation model projects a bull case target of $19 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

PATH is well covered by analysts, with 24 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 6 have Buy ratings, 16 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month PATH stock forecast based on 24 Wall Street analysts shows a consensus price target of $14, with estimates ranging from $12 (bear case) to $18 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $14, with bear/bull scenarios of $9/$19.

Our quantitative valuation model calculates PATH's fair value at $14 (base case), with a bear case of $9 and bull case of $19. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 65/100.

PATH trades at a forward P/E ratio of 17.3x based on next-twelve-months earnings estimates compared to a trailing P/E of 22.4x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on PATH, with a "Hold" consensus rating and $14 price target (20.2% upside). 6 of 24 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

PATH analyst price targets range from $12 to $18, a 43% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $14 consensus represents the middle ground. Our model's $9-$19 range provides an independent fundamental perspective.